United States Third Circuit

In an action against a drug maker alleging it engaged in deceptive conduct in the advertising of its new drug Nexium, dismissal of the complaint with prejudice is affirmed where: 1) although the Delaware Consumer Fraud Act (DCFA) exemption for advertising regulated by the Federal Trade Commission does not preclude plaintiffs' suit; nevertheless 2) federal law preempts the plaintiffs' state consumer fraud claims.

Appellate Information

• Argued 06/05/2007
• Decided 08/17/2007
• Published 08/17/2007

Judges

• Before: SMITH, COWEN, and SILER, Circuit Judges.

Court

• United States Third Circuit

Counsel

• For Appellant:
  
• Pamela S. Tikellis, A. Zachary Naylor, Chimicles & Tikellis, Wilmington, DE; Barbara J. Hart, Christopher McDonald, Labaton, Sucharow & Rudoff, New York, NY; Theodore M. Lieverman, Jeffrey L. Kodroff, Spector, Roseman & Kodroff, Philadelphia, PA; Steve W. Berman, Craig R. Spiegel (Argued), Hagens BermanSobol Shapiro, Seattle, WA, Counsel for Appellants.


• For Appellees:
  
• Jack B. Blumenfeld, Rudolph J. Scaggs, Jr., Lisa K. Whittaker, Morris, Nichols, Arsht & Tunnell, Wilmington, DE; Mark E. Haddad (Argued), Sidley Austin, Los Angeles, CA, Counsel for Appellee.